Quality & Patient Safety
In this podcast, Nancy Foster, Vice President for Quality and Patient Safety Policy at the AHA, is joined by Paul Skolnik, chair of medicine and an infectious disease specialist at Carillion Clinic in Roanoke, Virginia, to discuss what patients should know about getting care at a hospital during a…
.webreplay{
border: solid 2px #777;
padding: 15px 5px;
margin: 0 0 10px 15px;
}
@media (min-width:360px){
.webreplay{
min-width: 290px;
float: right;
}
}
On-demand Webinar
MktoForms2.loadForm("//app-sj20.marketo.com", "734-ZTO-041", 5772);
Should Zero Falls Be The…
In this podcast, Julia Resnick, senior program manager for Strategic Initiatives with AHA, explores the care redesign process with Joe Landsman, president and chief executive officer at The University of Tennessee Medical Center; and Dr. James Shamiyeh, senior vice president and chief quality…
A National Quality Forum task force released a report identifying opportunities to advance safe, appropriate, person-centered care over the next decade.
Listen to the webinar
View the presentation slides.
The Food and Drug Administration announced it is requesting manufacturers immediately withdraw all prescription and over-the-counter ranitidine drugs (commonly known by the brand name Zantac) from the market.
A new report from the Agency for Healthcare Research and Quality consolidates the latest evidence on 47 patient safety practices to help hospitals, primary care practices, long-term care facilities and other providers target and focus their patient safety efforts.
The United States Pharmacopeia Appeals Panel remanded the revised USP General Chapter standards <795> for nonsterile compounding and <797> for sterile compounding to an expert committee “for further engagement on the issues raised concerning the beyond-use date provisions.”
The Food and Drug Administration reported 55 injuries and one death involving an infusion pump and vital signs monitoring system.
Reps. Scott Peters, D-Calif., Eliot Engel, D-N.Y., Brett Guthrie, R-KY, Anna Eshoo, D-Calif., Richard Hudson, R-N.C., Michael McCaul, R-Texas, Kurt Schrader, D-Ore., and Gus Bilirakis, D-Fla., introduced the Preventing Drug Shortages Act (H.R. 6080).